Wil L. Iam Y. Chey

Wil L. Iam Y. Chey's AcademicInfluence.com Rankings

Wil L. Iam Y. Chey

Philosophy

#9055

World Rank

#12552

Historical Rank

Logic

#6055

World Rank

#7535

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Wil L. Iam Y. Chey's Degrees

Doctorate Medicine Stanford University
PhD Biomedical Sciences Stanford University

Why Is Wil L. Iam Y. Chey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wil L. Iam Y. Chey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Infliximab maintenance therapy for fistulizing Crohn's disease. (2004) (2059)
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. (2001) (311)
Electrogastrographic study of patients with unexplained nausea, bloating, and vomiting. (1980) (270)
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea (2000) (265)
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease (2002) (226)
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. (2004) (191)
Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. (1997) (186)
EXTERNAL PANCREATIC SECRETION IN DIABETES MELLITUS. (1963) (183)
Study of electromechanical activity of the stomach in humans and in dogs with particular attention to tachygastria. (1984) (168)
Gastric and small intestinal myoelectric dysrhythmia associated with chronic intractable nausea and vomiting. (1981) (155)
Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis (1999) (154)
Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. (1970) (146)
An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. (1990) (136)
Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans. (2003) (124)
Prevalence of Helicobacter pylori in Peptic Ulcer Patients in Greater Rochester, NY: Is Empirical Triple Therapy Justified? (1998) (121)
Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog. (1983) (117)
A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease. (2007) (110)
Studies on plasma motilin concentration and interdigestive motility of the duodenum in humans. (1980) (109)
Secretin, 100 years later (2003) (105)
Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. (1977) (103)
Infliximab for patients with refractory ulcerative colitis. (2001) (103)
A phase 1/2A Trial of STA 5326, an oral interleukin‐12/23 inhibitor, in patients with active moderate to severe Crohn's disease (2006) (100)
Neural Hormonal Regulation of Exocrine Pancreatic Secretion (2001) (99)
Motor responses of the sigmoid colon and rectum to exogenous cholecystokinin and secretin. (1973) (96)
Infliximab for refractory ulcerative colitis (2001) (90)
Plasma secretin, CCK, and pancreatic secretion in response to dietary fat in the rat. (1989) (90)
Inhibition of acid secretion by electrical acupuncture is mediated via beta-endorphin and somatostatin. (1996) (88)
Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. (1983) (84)
Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs (2003) (83)
Effect of rabbit antisecretin serum on postprandial pancreatic secretion in dogs. (1979) (81)
Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK☆ (2000) (79)
Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. (1996) (77)
Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. (1990) (76)
A physiological role of peptide YY on exocrine pancreatic secretion in rats. (1993) (75)
An important role of endogenous insulin on exocrine pancreatic secretion in rats. (1990) (73)
Plasma secretin concentrations in fasting and postprandial states in dog. (1979) (72)
Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY : Is empirical triple therapy justified? (1998) (72)
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA). (1973) (70)
Cause-and-effect relationship between motilin and migrating myoelectric complexes. (1983) (69)
Identification, characterization and distribution of motilin immunoreactivity in the rat central nervous system (1981) (68)
Diseases of the Gastrointestinal Tract (1974) (65)
Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. (1990) (62)
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea (2000) (61)
Mechanism of increased exocrine pancreatic secretion in pancreatic juice-diverted rats. (1986) (61)
Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1. (1994) (59)
Actions of cholecystokinin and secretin on the motor activity of the small intestine in man. (1974) (59)
Secretin is released by digestive products of fat in dogs. (1986) (57)
Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings. (1980) (57)
Infliximab for refractory ulcerative colitis. (2001) (55)
Gastric secretion and gastric mucosal morphology in chronic alcoholics. (1972) (54)
Mapping of motilin-immunoreactive Neurons of the rat brain (1981) (52)
Influence of the vagus nerve on release and action of secretin in dog. (1979) (52)
The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. (1984) (50)
Effects of a meal and gut hormones on plasma motilin and duodenal motility in dog. (1980) (50)
Secretin is an enterogastrone in the dog. (1981) (50)
Mechanism of cholecystokinin-induced contraction of the opossum gallbladder. (1990) (48)
Plasma secretin and gastrin responses to a meat meal and duodenal acidification in dogs. (1976) (44)
Watery diarrhea associated with pancreatic islet cell carcinoma. (1975) (44)
Rapid extraction of secretin from plasma by XAD-2 resin and its application in the radioimmunoassay of secretin. (1978) (43)
Effects of atropine on the action and release of secretin in humans. (1982) (43)
Plasma secretion and pancreatic secretion in response to liver extract meal with varied pH and exogenous secretin in the dog. (1982) (42)
Serial pH changes in the duodenal bulb during smoking. (1978) (41)
Simultaneous radioimmunoassay of Secretin and gastrin. (1976) (41)
Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients (2001) (40)
Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs. (1988) (39)
Alcohol and gastric mucosa. (1972) (39)
Neuronal regulation of the release and action of secretin-releasing peptide and secretin. (1995) (39)
Plasma secretin concentrations in fasting and postprandial state in man (1978) (39)
Mechanism of oleic acid-induced inhibition on gastric acid secretion in rats. (1991) (37)
Role of pancreatic enzymes on release of cholecystokinin-pancreozymin in response to fat. (1988) (37)
Three‐year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions (2006) (37)
Effect of motilin on the opossum upper gastrointestinal tract and sphincter of Oddi. (1983) (37)
Electric acupuncture stimulates non-parietal cell secretion of the stomach in dog. (1984) (35)
Radioimmunoassay of motilin. Validation and studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of dog. (1978) (34)
Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity (1983) (34)
Preparation of 125I-labeled secretin of high specific radioactivity. (1975) (34)
Secretin inhibits gastric acid secretion via a vagal afferent pathway in rats. (1998) (34)
Radioimmunoassay of secretin. A critical review and current status. (1980) (34)
Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs. (1984) (33)
Functional disorders of the digestive tract (1983) (33)
Secretin: Historical Perspective and Current Status (2014) (33)
Duodenal acidification releases cholecystokinin. (1985) (33)
Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretin. (2000) (32)
Gastric secretion in patients with chronic pancreatitis and in chronic alcoholics. (1968) (32)
Effect of pancreatic juice and trypsin on oleic acid-stimulated pancreatic secretion and plasma secretin in dogs. (1989) (32)
Effect of sodium oleate on plasma secretin concentration and pancreatic secretion in dog (1981) (32)
Smoking and duodenal ulcer. (1978) (31)
Intestinal mucosal hormones and motor function of the stomach in man. (1969) (31)
Somatostatinoma syndrome: does a clinical entity exist? (1983) (31)
PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression. (1998) (30)
A hormonal mechanism for the interdigestive pancreatic secretion in dogs. (1986) (30)
Cholinergic role on release and action of motilin (1983) (30)
Release of cholecystokinin and secretin by sodium oleate in dogs: molecular form and bioactivity. (1992) (29)
Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE2 (2000) (29)
Regulation of pancreatic exocrine secretion (1991) (29)
Maintenance Oral Pantoprazole Therapy Is Effective for Patients With Zollinger-Ellison Syndrome and Idiopathic Hypersecretion (2003) (29)
Mechanism of action of insulin on pancreatic exocrine secretion in perfused rat pancreas. (1994) (28)
Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (27)
Effect of pancreatic proteases on plasma cholecystokinin, secretin, and pancreatic exocrine secretion in response to sodium oleate. (1990) (27)
Role of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. (1988) (26)
Presence of biologically and immunologically active secretin-like substance in the mammalian brain (1985) (26)
Development of radioimmunoassay for motilin. (1978) (26)
Influence of pancreas on gastric secretion in dogs. (1967) (26)
Endogenous Nitric Oxide Mediates Pancreatic Exocrine Secretion Stimulated by Secretin and Cholecystokinin in Rats (2000) (26)
Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. (1996) (24)
Radioimmunoassay of vasoactive intestinal polypeptide. (1979) (24)
The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York. (1995) (23)
Actions and interactions of gut hormones and histamine on gastric secretion of acid in the rat. (1973) (23)
Evaluation of Tests of Pancreatic Function in Chronic Pancreatic Disease (1967) (23)
Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats. (2001) (23)
Physiological doses of secretin do not stimulate acute insulin release. (1980) (23)
Effect of cisapride and renzapride on gastrointestinal motility and plasma motilin concentration in dogs. (1997) (23)
Pituitary adenylate cyclase-activating peptide stimulates rat pancreatic secretion via secretin and cholecystokinin releases. (1998) (22)
Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats. (1990) (21)
Effect of electrical stimulation of the vagus on plasma motilin concentration in dog. (1981) (21)
Secretin is an enterogastrone in humans (1987) (20)
Radioimmunoassay of secretin (1980) (19)
Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity. (1983) (19)
24-Hour plasma secretin level and pancreatic secretion in dog (1980) (19)
Role of secretin on postprandial gastrin release in the dog: a further study. (1981) (19)
Radioimmunoassay of motilin (1978) (18)
Canine vagus nerve stores cholecystokinin-58 and -8 but releases only cholecystokinin-8 upon electrical vagal stimulation (2000) (18)
A secretin releasing peptide exists in dog pancreatic juice. (2000) (18)
Purification of two secretin-releasing peptides structurally related to phospholipase A2 from canine pancreatic juice. (1999) (18)
Neural control of the release and action of secretin. (2003) (18)
Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2). (2000) (18)
Studies on mechanism of retching and vomiting in dogs (2005) (18)
Enterohepatic circulation is essential for regular cycling of duodenal migrating motor complexes in dogs. (1992) (18)
Radioimmunoassay of cholecystokinin (1983) (17)
Significant cholinergic role in secretin-stimulated exocrine secretion in isolated rat pancreas. (1998) (17)
Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects (1986) (17)
Diagnosis of diseases of the pancreas and biliary tract. Evaluation of pancreozymin-secretin test. (1966) (17)
Solid-phase synthesis and biological activities of gastrointestinal hormones: Secretin and motilin (1982) (17)
Effect of Endogenous Insulin on Pancreatic Exocrine Secretion in Perfused Dog Pancreas (1995) (17)
Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs. (1989) (17)
Continuous Wavelet Analysis as an Aid in the Representation and Interpretation of Electrogastrographic Signals (1996) (17)
Effects of ethanol on the gastric mucosa of the Heidenhain pouch of dogs (1970) (16)
Role of secretin in basal and fat-stimulated pancreatic secretion in conscious rats. (1991) (16)
Experiences with the treatment of alkaline reflux gastritis. (1980) (16)
Role of GRPergic neurons in secretin-evoked exocrine secretion in isolated rat pancreas. (2000) (16)
The release of biologically active secretin‐like immunoreactivity into duodenal lumen of dogs. (1981) (15)
Effect of cisplatin on myoelectric activity of the stomach and small intestine in dogs (1988) (15)
Pancreatic phospholipase A2 from the small intestine is a secretin-releasing factor in rats. (2001) (15)
Infliximab is an effective therapeutic agent for ulcerative colitis (2000) (15)
Roles of gut hormones in negative-feedback regulation of pancreatic exocrine secretion in humans (1994) (15)
Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy. (2000) (14)
Impairment of secretin release in celiac sprue (1978) (14)
Observations on plasma secretion levels by radioimmunoassay in response to duodenal acidification and to a meat meal in humans (1976) (14)
ABSORPTION OF FATS AND EXTERNAL PANCREATIC SECRETION. (1963) (14)
Galanin inhibits cholecystokinin secretion in STC-1 cells. (1995) (14)
Effects of exogenous secretin on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma secretin levels (1985) (14)
Effect of 13-norleucin motilin on water and ion transport in the human jejunum (1984) (13)
Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases (1981) (13)
Canine pancreatic juice stimulates the release of secretin and pancreatic secretion in the dog. (1999) (13)
Normal fasting volume and postprandial emptying of the denervated donor gallbladder in liver transplant recipients. (1994) (13)
Increased interdigestive pancreatic trypsin secretion in alcoholic pancreatic disease (1985) (12)
Giant fundic polyp complicating attenuated familial adenomatous polyposis (2000) (12)
PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression. (1998) (11)
Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide. (1978) (11)
Methyldopa-induced pancreatitis (1978) (11)
Actions of motilin on gastrointestinal motility and plasma immunoreactive motilin concentration in interdigestive and postprandial states. (1980) (11)
Hemangioendotheliomaitosis of the Liver: A 12-year follow-up (1977) (10)
Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins. (1994) (10)
Presence of a Secretin-releasing Peptide (1990) (10)
Evidence on the presence of secretin cells in the gastric antral and oxyntic mucosa (2003) (10)
Secretion cells in the gastrointestinal tract. (1976) (10)
A randomized, placebo-controlled trial of an antisense ICAM-1 inhibitor (ISIS 2302) in steroid-dependent Crohn's disease showed clinical improvement at high serum levels (2001) (10)
Neurohormonal regulation of secretin secretion in canine duodenal mucosa in vitro (1986) (9)
Neurohormonal mechanism of pancreatic exocrine secretion stimulated by sodium oleate and L-tryptophan in dogs. (1992) (9)
Effect of alcohol on plasma secretin concentration and pancreatic secretion in dogs. (1984) (9)
Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist (1999) (9)
Modulation of gallbladder contraction by pirenzepine in humans. (1995) (9)
Effect of motilin on the lower esophageal sphincter of the opossum (1977) (9)
Release of Secretin by Licorice Extract in Dogs (1986) (9)
Effects of chronic administration of ethanol on gastric secretion of acid in dogs (1972) (8)
Effect of 1-phenylpentanol on release of secretin and exocrine pancreatic secretion in dogs and humans. (1983) (8)
Effect of 1-phenylpentanol on release of secretin and exocrine pancreatic secretion in dogs and humans (1983) (8)
Effect of [(CH2NH)4,5]secretin on pancreatic exocrine secretion in guinea pigs and rats. (1993) (8)
Significant cholinergic role in secretin-stimulated exocrine secretion in isolated rat pancreas. (1998) (7)
Motilin Release and the Migrating Myoelectric Complexes (1984) (7)
Use of secretin in hypotonic duodenography. (1974) (7)
Negative Feedback Regulation of Pancreatic Exocrine Secretion in Guinea Pigs (1995) (7)
Roles of the vagus in endogenous release of secretin and exocrine pancreatic secretion in dog. (1978) (6)
Neurohormonal control of exocrine pancreas. (2001) (6)
Chapter 3: Bowel Disorders (2016) (6)
OBSERVATIONS ON THE MECHANISM AND TREATMENT OF ASCITES IN HEPATIC CIRRHOSIS (1962) (5)
Pancreatic function diagnostant (1981) (5)
Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome. (2008) (5)
Comment on the comment of Dr. Daniel Present (2002) (5)
Alternative synthesis of porcine secretin and apparent autolysis of the product. (1985) (5)
The effect of electroacupuncture on gastric secretion in dog. (1985) (5)
Pancreatic exocrine function in chronic alcoholics. (1971) (4)
Mechanism of gastric acid hypersecretion in patients with islet cell tumor without hypergastrinemia: studies in rats. (1997) (4)
[The effect of bile on endogenous secretin release]. (1982) (4)
Intestinal Epithelial Cells and Innate Immunity in the Intestine: Is CARD15/Nod2 Another Player? (2003) (4)
Motilin-antimotilin reaction reveals two antigenic determinants in motilin (1981) (4)
Effect of Digested Protein on Pancreatic Exocrine Secretion and Gut Hormone Release in the Dog (1994) (4)
MECHANISMS ON THE RELEASE AND PHYSIOLOGICAL ACTIONS OF SECRETIN (1994) (4)
Gastrointestinal disorders in chronic alcoholics. (1971) (4)
A Nongastrin Malignant Ampullary Tumor Causing Gastric Acid and Pepsin Hypersecretion A Case Report (1990) (4)
CCK-receptor antagonists proglumide and loxiglumide stimulate bile flow and biliary glutathione excretion (1994) (4)
Aspirin Inhibits Secretagogue‐Stimulated and Postprandial Pancreatic Exocrine Secretion in Conscious Rats (1995) (3)
Observations on therapeutic effect of Infliximab on ulcerative colitis (2001) (3)
Observations on hepatic histology and function in alcoholic dogs (1971) (3)
Acid secretion during indomethacin therapy. Effect of misoprostol. (1995) (3)
Rapid, small-scale preparation of gastrointestinal hormones by high-performance liquid chromatography on a C18 column. (1985) (3)
What is the impact of Tegaserod on gallbladder emptying? (2003) (3)
Hemangioendotheliomatosis of the liver. A 12-year follow-up. (1977) (2)
Primary Pancreatic Secretinoma: Further Evidence Supporting Secretin as a Diarrheogenic Hormone (2017) (2)
Actions of synthetic porcine motilin, octapeptide of cholecystokinin (CCK), gastric inhibitory polypeptide (GIP) and secretin on myoelectrical activity of gastric antrum and doudenum (1976) (2)
Geranyl‐Geranyl Acetone: A Novel Stimulant of Secretin Release in the Dog (1990) (2)
Immunoreactive secretin and exocrine pancreatic secretion (1978) (2)
Effect of a meat meal and gut hormones on plasma immunoreactive motilin (PIM) concentrations and myoelectric activity of the duodenum in dogs (1978) (2)
A Physiological Role of Peptide YY on Exocrine Secretion in Rats Pancreatic (1993) (2)
Gastro-colic Reflex (2004) (1)
Infliximab for ulcerative colitis. (2005) (1)
Immunoreactive secretin and exocrine pancreatic secretion. (1978) (1)
Effect of oral bethanechol on symptoms and endoscopic findings of reflux esophagitis (1978) (1)
Faculty Opinions recommendation of Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. (2018) (1)
Effect of Dopamine or Dopamine Blocker on the Antral Motility in Isolated Perfused Rat Stomach (1984) (1)
13 – Endogenous Motilin Release: Physiology and Pathophysiology (1990) (1)
[The effect of pancreatic juice diversion on plasma secretin level and pancreatic secretion in postprandial state in dogs (author's transl)]. (1981) (1)
Linear prediction of canine gastric signals (1988) (1)
Secretin inhibits gastric acid secretion via a vagal afferent pathway in rats. (1998) (1)
Observations on the ultrastructure of oxyntic cells in alcohol-fed dogs (1973) (1)
[Surgical treatment of chronic idiopathic constipation]. (1993) (1)
INFLAMMATORY BOWEL DISEASE Double blind , placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide , alicaforsen ( ISIS 2302 ) , in active steroid dependent Crohn ’ s disease (2002) (1)
Ectopic pancreatic adenocarcinoma presenting as gastric outlet obstruction (2000) (1)
Second International Conference on Gastrointestinal Hormones (1979) (1)
5-Hydroxytryptamine (5-HT) receptors mediate the release and action of secretin on pancreatic secretion induced by duodenal acidification in rats (1998) (1)
Mechanism of action of licorice extract on exocrine pancreas in dogs (1984) (1)
Sphincter of Oddi and gastrointestinal motility disturbance following alcohol administration in the opossum (1986) (1)
Effect of 13-norleucin motilin on water and ion transport in the human jejunum. (1984) (1)
Motility abnormality in dogs with gastrojejunostomy. (1986) (1)
Faculty Opinions recommendation of The intestinal microenvironment and functional gastrointestinal disorders. (2018) (0)
Faculty Opinions recommendation of Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. (2018) (0)
Invited commentary (1979) (0)
Canine pancreatic juice stimulates the release of secretin and pancreatic secretion in the dog. (1999) (0)
Somatostatin released from STC-1 cells is not involved in autocrine regulation of secretin and CCK release (2000) (0)
Serum gastrin levels are not elevated in patients with pancreatic adenocarcinoma (1998) (0)
What is the impact of Tegaserod on gallbladder emptying (2003) (0)
Faculty Opinions recommendation of Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating. (2018) (0)
Successful detection and treatment of duodenal gastrinoma (2000) (0)
Development of isolated perfused whole stomach for motility study in rat and cat (1984) (0)
Eluxadoline Demonstrates Efficacy for the Treatment of Irritable Bowel Syndrome (IBS) With Diarrhea (IBS-D) Among Multiple Clinically Relevant Patient Subgroups: 1760 (2015) (0)
Chapter 11: Bowel Disorders (2016) (0)
The endocrine control of gastrointestinal function. (1978) (0)
Milk meal in children; gastrin response. (1980) (0)
Pseudo-obstruction associated with ICC abnormalities, hyperplasia and lymphocyte infiltration (2000) (0)
Faculty Opinions recommendation of Volatile organic compounds in feces associate with response to dietary intervention in patients with irritable bowel syndrome. (2018) (0)
[Discovery and rediscovery of secretin (author's transl)]. (1981) (0)
and pancreatic secretion in the dog Canine pancreatic juice stimulates the release of secretin (2016) (0)
Endogenous motilin release is cholinergic dependent: A further study (1983) (0)
ABSENCE OF IN-UTERO AMNIOTIC FLUID SWALLOWING IS ASSOCIATED WITH DECREASED CORD BLOOD TROPHIC GUT PEPTIDE LEVELS. † 701 (1996) (0)
Joy of scientific pursuance and medical practice, an art. (2002) (0)
Community Wide Analysis of IBD in Rochester, New York, January 1973 to December 1989L Epidemiologic Description with Detailed Clinical Analysis (1993) (0)
Faculty Opinions recommendation of Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment. (2018) (0)
Faculty Opinions recommendation of Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. (2018) (0)
Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (0)
Role of prostaglandins in oleic acid and secretin mediated inhibition of human gastric acid secretion (1992) (0)
[Effect of alcohol ingestion on plasma secretin and exocrine pancreatic secretion]. (1984) (0)
The cellular mechanism of sodium oleate-stimulated CCK release from STC-1 cells* (1998) (0)
enetic Testing and Phenotype in a Large Kindred With ttenuated Familial Adenomatous Polyposis (2004) (0)
Synergistic stimulation of CCK secretion from STC-1 cells by sodium oleate and amino acids (2000) (0)
Comment on the comment of Dr. Daniel Present. (2002) (0)
[Ulcerous disease of endocrinal origin caused by a non-gastric substance]. (1991) (0)
Central secretin mediates pancreatic exocrine secretion in rats (2000) (0)
Pancreatic function diagnostant: Edited by Masasuke Masuda. 144 pp., $22.50. Igaku-Shoin, Tokyo, Japan, 1980 (1981) (0)
Utilization Of Linear Prediction And Nonlinear Filtering For The Enhancement Of Canine Gastric Signals (1990) (0)
Will Transplantation of an Hepatitis C-Infected Graft Improve the Outcome of Liver Transplantation in HCV Patients? (1999) (0)
Faculty Opinions recommendation of Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. (2018) (0)
Protective mechanism of teprenone in the isolated vascularly perfused rat stomach (1998) (0)
Cisapride and renzapride stimulate plasma motilin release and gastrointestinal motility in dogs (1992) (0)
Faculty Opinions recommendation of Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. (2018) (0)
Faculty Opinions recommendation of Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. (2018) (0)
Faculty Opinions recommendation of Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. (2018) (0)
CHAPTER 153 – Secretin (2006) (0)
Original contributionMaintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion☆ (2003) (0)
Galanin inhibits sodium oleate-stimulated CCK release from STC-1 cells* (1998) (0)
AGI April 41/4 (2000) (0)
International symposium “Functional disorders of the digestive tract” (2007) (0)
Catabolism of gastrin secretin. Invited commentary. (1979) (0)
Comprar Irritable Bowel Syndrome, An Issue of Gastroenterology Clinics | William Y. Chey | 9781455704507 | Saunders (2011) (0)
Secretin inhibits vagal afferent nerve discharge in response to gastric distension in rats (2000) (0)
Release of cholecystokinin by proximal gut fat is independent of chylomicron transport (1998) (0)
Alosetron improves bowel function in dumping syndrome patients (2000) (0)
Malrotation of gastric fundus is a cause of functional dyspepsia; endoscopic gastropexy is an effective treatment (2003) (0)
Multistage enhancement of surface recordings of canine gastric electrical signals (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wil L. Iam Y. Chey?

Wil L. Iam Y. Chey is affiliated with the following schools: